
GYRE P/E Ratio
P/E Ratio as of Jul 2, 2025: 162.84
Average166.62
Median167.22
Minimum153.44
Maximum187.89
162.84
Past Month-26.51 (14.00%)
The P/E ratio for GYRE is 162.84 as of Jul 2, 2025. This represents a increase of 340.11% compared to its 12-month average P/E ratio of 37. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Gyre Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Gyre Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Gyre Therapeutics Inc to industry peers.
Gyre Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Gyre Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Gyre Therapeutics Inc to industry peers.
GYRE P/E Ratio Insights
See Gyre Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in GYRE
Order type
Buy in
Order amount
Est. shares
0 shares
GYRE P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $7.46 | 155.74 |
Jun 2, 2025 | $7.68 | 160.33 |
May 1, 2025 | $9.34 | 79.83 |
Apr 1, 2025 | $6.41 | 53.78 |
Mar 3, 2025 | $11.43 | -0.65 |
Feb 3, 2025 | $11.57 | -0.66 |
Jan 2, 2025 | $12.00 | -0.68 |
GYRE End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 162.84 | -23,700.00% |
2024 | -0.69 | -52.74% |
2023 | -1.46 | -439.53% |
2022 | 0.43 | -1,533.33% |
2021 | -0.03 | -83.33% |
2020 | -0.18 | — |
FAQs About Gyre Therapeutics Inc (GYRE) P/E ratio
The latest P/E ratio of GYRE is 162.84, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Gyre Therapeutics Inc’s last 12-month average P/E ratio is 37, compared to its current P/E ratio of 162.84. This reflects a increase of 340.11%.
Gyre Therapeutics Inc’s current P/E ratio of 162.84 is higher than its last 12-month average P/E of 37. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Gyre Therapeutics Inc’s average P/E ratio over the last 3 years is 11.72. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Gyre Therapeutics Inc’s average P/E ratio over the last 5 years is 6.98. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.